Mastocytosis presenting with mast cell‐mediator release‐associated symptoms elicited by cyclo oxygenase inhibitors: prevalence, clinical, and laboratory features

Abstract Background Nonsteroidal anti‐inflammatory drugs (NSAIDs) are frequently avoided in mastocytosis, because of a potential increased risk for drug hypersensitivity reactions (DHRs) due to inhibition of cyclo‐oxygenase (COX), subsequent depletion of prostaglandin E2 and release of leukotrienes....

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Tiago Azenha Rama, José Mário Morgado, Ana Henriques, Luis Escribano, Iván Alvarez‐Twose, Laura Sanchez‐Muñoz, André Moreira, José Romão, Alberto Órfão, Almudena Matito
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Wiley 2022-03-01
Saila:	Clinical and Translational Allergy
Gaiak:	anaphylaxis mast cell‐mediator release‐associated symptoms mast cells mastocytosis non‐steroidal anti‐inflammatory drug hypersensitivity
Sarrera elektronikoa:	https://doi.org/10.1002/clt2.12132
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!